These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15589019)

  • 21. Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus.
    Fogari R; Zoppi A; Mugellini A; Corradi L; Lazzari P; Preti P; Derosa G
    J Cardiovasc Pharmacol; 2008 Mar; 51(3):217-22. PubMed ID: 18356684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness and side effects of the treatment with propafenone and flecainide for recent-onset atrial fibrillation].
    Romano S; Fattore L; Toscano G; Corsini F; Coppo A; Catanzaro M; Romano A; Martone A; Caccavale F; Iodice E; Di Maggio O; Corsini G
    Ital Heart J Suppl; 2001 Jan; 2(1):41-5. PubMed ID: 11216083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost evaluation of rhythm control methods for atrial fibrillation: evidence from CTAF.
    Nattel S; Lumer G; Talajic M; Roy D
    Card Electrophysiol Rev; 2003 Sep; 7(3):211-4. PubMed ID: 14739715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation.
    Lee SH; Chen SA; Tai CT; Chiang CE; Wen ZC; Chen YJ; Yu WC; Huang JL; Fong AN; Cheng JJ; Chang MS
    Am J Cardiol; 1997 Apr; 79(7):905-8. PubMed ID: 9104904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial fibrillation and the pharmacological treatment: the role of propafenone.
    Sestito A; Molina E
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):242-53. PubMed ID: 22428477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects].
    Alboni P; Botto GL; Baldi N
    Ital Heart J Suppl; 2005 Jun; 6(6):335-40. PubMed ID: 16013424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
    Vijayalakshmi K; Whittaker VJ; Sutton A; Campbell P; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
    Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study.
    Kochiadakis GE; Igoumenidis NE; Marketou ME; Kaleboubas MD; Simantirakis EN; Vardas PE
    Heart; 2000 Sep; 84(3):251-7. PubMed ID: 10956284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of substituting innovator propafenone for its generic formulation in patients with atrial fibrillation.
    Amit G; Rosen A; Wagshal AB; Bonneh DY; Liss T; Grosbard A; Ilia R; Katz A
    Am J Cardiol; 2004 Jun; 93(12):1558-60. PubMed ID: 15194037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propafenone for the prevention of atrial tachyarrhythmias after cardiac surgery: a randomized, double-blind placebo-controlled trial.
    Mörike K; Kivistö KT; Schaeffeler E; Jägle C; Igel S; Drescher S; Fux R; Marx C; Hofmann U; Engel C; Wagner F; Delabar U; Meisner C; Bail D; Böhm JO; Gleiter CH; Ziemer G; Rein JG; Hellberg KD; Eichelbaum M; Schwab M
    Clin Pharmacol Ther; 2008 Jul; 84(1):104-10. PubMed ID: 18167502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
    Pappone C; Augello G; Sala S; Gugliotta F; Vicedomini G; Gulletta S; Paglino G; Mazzone P; Sora N; Greiss I; Santagostino A; LiVolsi L; Pappone N; Radinovic A; Manguso F; Santinelli V
    J Am Coll Cardiol; 2006 Dec; 48(11):2340-7. PubMed ID: 17161267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study.
    Dogan A; Ergene O; Nazli C; Kinay O; Altinbas A; Ucarci Y; Ergene U; Ozaydin M; Gedikli O
    Acta Cardiol; 2004 Jun; 59(3):255-61. PubMed ID: 15255456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.
    Li X; Zhang Y; Liu H; Jiang H; Ge H; Zhang Y
    Am J Cardiol; 2017 May; 119(9):1366-1370. PubMed ID: 28283175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
    Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
    Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term efficacy and safety of very-low-dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct-current cardioversion.
    Jong GP; Chang MH; Chang TC; Chou P; Fu CY; Tien LY; Chen CY; Ma TC
    Chin Med J (Engl); 2006 Dec; 119(24):2030-5. PubMed ID: 17199952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
    Fragakis N; Papadopoulos N; Papanastasiou S; Kozirakis M; Maligkos G; Tsaritsaniotis E; Katsaris G
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):954-61. PubMed ID: 16176535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of oral propafenone for the prevention of atrial fibrillation after coronary artery bypass grafting.
    Kowey PR; Yannicelli D; Amsterdam E;
    Am J Cardiol; 2004 Sep; 94(5):663-5. PubMed ID: 15342305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators.
    Stroobandt R; Stiels B; Hoebrechts R
    Am J Cardiol; 1997 Feb; 79(4):418-23. PubMed ID: 9052343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm.
    Capucci A
    Am J Cardiol; 1998 Feb; 81(3):373-4. PubMed ID: 9468092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.